Navigation Links
Expanded Cardiovascular Care Services on Long Island
Date:9/10/2009

NEW YORK, Sept. 10 /PRNewswire/ -- The Mount Sinai Medical Center has joined with Long Island Heart Associates in an affiliation agreement that will bring world-class clinical and surgical cardiovascular care to patients on Long Island.

"The clinical and diagnostic expertise at Long Island Heart Associates made it an ideal match for our cardiovascular center of excellence, Mount Sinai Heart," said Wayne E. Keathley, President and Chief Operating Officer of The Mount Sinai Hospital. "Together we will offer patients on Long Island the most advanced and innovative therapies for heart disease available today."

The new affiliation will streamline services for patients, who will gain access to world-renowned heart specialists and the most modern screening and imaging centers without the hassle of making appointments or waiting for them.

"The seamless communication and coordination of services between the two organizations will translate into quicker access to renowned physicians, faster test results, and a more satisfying experience for patients," said Mr. Keathley.

Long Island Heart Associates has served the area since 1994 and currently has nine physicians in six locations in Long Island and Queens. It offers patients state-of-the-art diagnostic care, an on-site nuclear lab, 24-hour pre-operative clearance, a hotel-style sleep lab, and the resources of the New York Heart Research Foundation.

Mount Sinai Heart, one of the nation's leading centers for cardiac research and clinical care, will appoint a representative to Long Island Heart Associates offices to meet with patients and coordinate their care at Mount Sinai. A Mount Sinai cardiologist will also consult with patients at Long Island Heart Associates offices on a regular basis. Transportation will be provided to and from Mount Sinai's Manhattan campus for patients undergoing certain procedures.

"Long Island Heart Associates is now affiliated with the best academic medical center in New York City," said Steven Shayani, MD, Medical Director of Long Island Heart Associates. "Our patients have access to the latest and most advanced cardiovascular research, education and treatment. By complementing our resources with Mount Sinai's, we are truly providing our Long Island patients with the very best care available anywhere in the world."

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation's oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.

Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. For more information, please visit www.mountsinai.org.


'/>"/>
SOURCE The Mount Sinai Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
2. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
3. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
4. Eularis Announces New Corporate Name and Expanded Product Offerings
5. E. Coli Registry Expanded for Victims of E. Coli Poisoning from Cargill Ground Beef
6. AMDL Launches Expanded Distribution With 4th Round of Agreements Valued at $6.79 Million Annually for New Health & Beauty Product Line
7. Mexicos expanded health insurance improves hypertension treatment
8. Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients
9. Expanded Options for Medicare Beneficiaries in Oklahoma
10. TriWest Earns Expanded URAC Accreditation
11. Zipfizz(R) Announces Expanded Distribution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... KS (PRWEB) , ... January 18, 2017 , ... ... firm offering asset protection and financial planning services to families and business owners ... charity event aimed at supporting children with developmental disabilities. , The Lakemary Center ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that Mr. Michael Merges, Director of Strategic Growth, ... be held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, ...
(Date:1/18/2017)... Lebanon, NH (PRWEB) , ... January 18, 2017 ... ... the launch of the revolutionary Active Brake Technology (ABT), an innovative braking system ... stability. , Active Brake Technology addresses one of the biggest concerns of beginner ...
(Date:1/17/2017)... ... ... January is National Stalking Awareness Month (NSAM), now in its fourteenth year, when ... the crime of stalking, a very real danger to many in our community. We ... and other crimes. , “Stalking: know it. Name it. Stop it.”—so reads the theme for ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SHANGHAI , Jan. 18, 2017 In ... of revolution, which is where the Upgrade of ... year of the 13th Five-Year Plan for Economic and Social ... (the 13th Five-Year Plan), and the state council of ... the "13th Five-Year" national strategic emerging industry development plan, identifying ...
(Date:1/18/2017)... Invetech, the leading developer of ... , has announced a collaboration agreement with Erytech ... treatments for acute leukemia and other oncology indications ... will develop systems to enable the commercial-scale manufacture ... platform, which uses a novel technology to encapsulate ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology: